Dimitrios Kolokouris

Dimitrios Kolokouris is a Postdoctoral Associate Scientist at the Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen. His research focuses on membrane protein biochemistry, particularly SLC transporters (constituting 5% of the human genome), and their role in diseases like cancer and autoimmune disorders, aiming to develop novel pharmacotherapies through structural biology and drug design.

His educational background includes:

• D.Phil (Ph.D) from the University of Oxford
• Master in Pharmacy (M.Pharm) with distinction from the National and Kapodistrian University of Athens

Kolokouris specializes in protein chemistry, structural biology, and computational analysis of membrane transport mechanisms. He employs Cryo-EM, crystallography, and biophysics to study SLC transporters, drawing parallels to existing therapeutics like SSRIs. His work bridges fundamental molecular mechanisms with preclinical assay development for next-generation drug targets.

His 2025 publication on influenza virus A M2 viroporin inhibition exemplifies his focus on molecular biophysics and antiviral drug challenges, spanning virology, structural pharmacology, and resistance mechanisms. This aligns with his broader expertise in protein dynamics and therapeutic targeting of membrane proteins.

No scientific awards or student advising details are mentioned. As an EU-licensed pharmacist, Kolokouris integrates clinical perspective with cross-functional collaboration in structural drug design and complex data communication.